The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise (DIMITOS)
|ClinicalTrials.gov Identifier: NCT02948673|
Recruitment Status : Completed
First Posted : October 28, 2016
Last Update Posted : May 2, 2018
Objectives: The research focus of the study is the production of reactive oxygen species (ROS) in patients with type 2 diabetes (T2D) in response to glutathione (GSH) supplementation and in response to acute exercise.
Oxidative stress is suggested as a possible causative factor in the pathophysiology of skeletal muscle insulin resistance. GSH is the most abundant endogenous antioxidant in the cell and thus, a crucial protector against oxidative stress and insulin resistance. It has been found that patients with T2D have a decreased level of GSH in plasma and that 1 h GSH infusion improves skeletal muscle glucose uptake by ~25% and the redox environment in patients with T2D. Therefore, we want to investigate the effect of 3 months of GSH supplementation on skeletal muscle insulin sensitivity and mitochondrial ROS production in patients with T2D and healthy controls.
Hypothesis: Oral GSH supplementation will improve skeletal muscle insulin sensitivity in patients with T2D and this effect will be linked to a reduced mitochondrial ROS production in the skeletal muscle.
In contrast to the link between oxidative stress and insulin resistance, ROS produced in response to exercise is an important physiological stimulus as it is suggested to play a key role in the beneficial mitochondrial biogenesis observed in response to training. It has been reported that some patients with T2D have a diminished mitochondrial biogenesis in response to training, but the reason for this defect is not known. We want to investigate the link between exercise-stimulated ROS production and the mitochondrial biogenesis response in patients with T2D and healthy controls in response to acute exercise at two different intensities.
Hypothesis: Considering the pathological condition of T2D skeletal muscle (i.e. high chronic ROS level), we speculate that a lower exercise intensity, leading to a lower exercise-stimulated ROS production is a more optimal stimulus (i.e. not to high) for mitochondrial biogenesis in patients with T2D.
|Condition or disease||Intervention/treatment||Phase|
|Type 2 Diabetes Oxidative Stress Mitochondrial Reactive Oxygen Species Production||Dietary Supplement: Glutathione Other: Placebo||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Double (Participant, Investigator)|
|Primary Purpose:||Basic Science|
|Official Title:||The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise in Patients With Type 2 Diabetes|
|Study Start Date :||May 2016|
|Actual Primary Completion Date :||December 2017|
|Actual Study Completion Date :||December 2017|
Placebo Comparator: Control
4 placebo tablets/day (2 in the morning and 2 in the evening)
4 oral placebo tablets for 4 weeks
Active Comparator: Glutathione
4 oral GSH tablets/day (2 in the morning and 2 in the evening)
Dietary Supplement: Glutathione
4 oral GSH tablets/day (1000mg/day) for 4 weeks
Other Name: Setria Glutathion
- Insulin sensitivity [ Time Frame: 12 weeks ]Difference in insulin sensitivity (measured as glucose infusion rate during a hyperinsulinaemic euglycaemic clamp) between patients with type 2 diabetes receiving glutathione supplementation and patients with type 2 diabetes receiving placebo.
- Mitochondrial reactive oxygen species production [ Time Frame: 12 weeks ]Difference in the mitochondrial reactive oxygen species production between patients with type 2 diabetes receiving glutathione supplementation and patients with type 2 diabetes receiving placebo.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02948673
|Xlab, Department of Biomedical Sciences, Faculty Of Health Sciences, University of Copenhagen|
|Copenhagen, Nørrebro, Denmark, 2200|
|Principal Investigator:||Steen Larsen, Ass. prof.||University of Copenhagen|